Cipla gains as its arm receives approval for generic version of Pfizer’s Lyrica

22 Jul 2019 Evaluate

Cipla is currently trading at Rs. 538.05, up by 0.85 points or 0.22% from its previous closing of Rs. 536.85 on the BSE.

The scrip opened at Rs. 532.90 and has touched a high and low of Rs. 538.40 and Rs. 525.85 respectively. So far 19446 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 678.00 on 19-Sep-2018 and a 52 week low of Rs. 483.75 on 29-Jan-2019.

Last one week high and low of the scrip stood at Rs. 562.70 and Rs. 525.85 respectively. The current market cap of the company is Rs. 43155.30 crore.

The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 40.81% and 22.49% respectively.

Cipla’s wholly-owned subsidiary -- InvaGen Pharmaceuticals, Inc. has received final approval for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg from the United States Food and Drug Administration (USFDA).

InvaGen’s Pregabalin Capsules is AB-rated generic therapeutic equivalent version of Pfizer’s Lyrica. Pregabalin capsules are indicated for management of neuropathic pain associated with diabetic peripheral neuropathy, management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, management of fibromyalgia and management of neuropathic pain associated with spinal cord injury.

According to IQVIA (IMS Health), Lyrica had US sales of approximately $5.4 billion for the 12-month period ending March 2019. The product is available for shipping immediately.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1388.00 -35.40 (-2.49%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.